Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Kaleido Biosciences Shares Plunging To 52-Week Low, Read Why

  • Kaleido Biosciences Inc (NASDAQ:KLDO) has delivered formal notice to voluntarily delist its common stock from NASDAQ as the Company will stop all operations.
  • The Company expects to file a Form 25 with the Securities and Exchange Commission by April 18 to effect the voluntary delisting effective by April 28.
  • The Board of Directors voted to immediately wind down and cease all of the Company’s ongoing operations. 
  • Related: Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target.
  • In connection with the cessation of activities, the employment of all of the Company’s remaining employees was terminated effective immediately. 
  • As previously announced, the Company had initiated a strategic process, but it did not result in the identification of any viable transactions, given its limited remaining resources.
  • The Company cannot continue operations and believes that the best alternative is an orderly wind-down process. 
  • Price Action: KLDO shares are down 74.9% at $0.37 during the market session on the last check Friday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.